Work

BiovaxID Vaccine Therapy of Follicular Lymphoma in First Remission: Phase III Blinded Safety Update.

Year: 2007

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood.v110.11.4500.4500

Authors: Angelos M. Stergiou, Sattva S. Neelapu, Roman Casciano, Margo A. Jaffee, Larry W. Kwak

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2595388750

FWCI: 0.707

Cites:

Cited by: 4

Related to: 10